Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients.

Beraud, Mickael; Goodhue Meyer, Erin; Lozano, Miquel; Bah, Aicha; Vassallo, Ralph; Brown, Bethany L

Beraud, Mickael; Goodhue Meyer, Erin; Lozano, Miquel; Bah, Aicha; Vassallo, Ralph; Brown, Bethany L.

Affiliation

Beraud M; Terumo Blood and Cell Technologies Europe NV, Ikaroslaan 41, 1930, Zaventem, Belgium. Electronic address: Mickael.Beraud@terumobct.com.
Goodhue Meyer E; Terumo Blood and Cell Technologies, 10811 W Collins Ave, Lakewood, CO, 80215, United States. Electronic address: Erin.Goodhue@terumobct.com.
Lozano M; Department of Hemotherapy and Hemostasis, ICMHO, University Clinic Hospital, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Catalonia, Spain. Electronic address: mlozano@clinic.cat.
Bah A; Terumo Blood and Cell Technologies Europe NV, Ikaroslaan 41, 1930, Zaventem, Belgium. Electronic address: Aicha.Bah@terumobct.com.
Vassallo R; Vitalant, 6210 E Oak St, Scottsdale, AZ, 85257, United States. Electronic address: RVassallo@vitalant.org.
Brown BL; American Red Cross, Biomedical Services, Holland Laboratory for the Biomedical Sciences, 15601 Crabbs Branch Way, Rockville, MD, 20855, United States. Electronic address: bethany.brown2@redcross.org.

Transfus Apher Sci ; 61(3): 103355, 2022 Jun.

Article de En | MEDLINE | ID: mdl-35063360

Sujet(s)
Mots clés

COVID-19; Convalescent plasma; Efficacy; Immunosuppression; Pandemic; Safety

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 Type d'étude: Prognostic_studies / Systematic_reviews Limites: Humans Langue: En Journal: Transfus Apher Sci Sujet du journal: HEMATOLOGIA Année: 2022 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google